Point Of Care Lipid Test Market Size, Share, and Trends Report by Product Category

 Save 30% on All Global Market Reports With Code ONLINE30 — Gain Insights Into Tariffs, Inflation, and Industry Trends

 

 What Is the Projected Growth Rate of the Point Of Care Lipid Test Market Through 2029?
 The point of care lipid test market size has grown strongly in recent years. It will grow from $0.68 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of cardiovascular disease and dyslipidemia, growth of multi-analyte and multiplex testing, increasing healthcare expenditure & reimbursement support, growing awareness and emphasis on preventive healthcare, and wider adoption in retail pharmacies, clinics, and community settings.
 
 The point of care lipid test market size is expected to see strong growth in the next few years. It will grow to $1.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption in home-based and self-monitoring settings, rising awareness and screening for genetic lipid disorders, increasing chronic disease burden, the shift toward value-based healthcare models, and stable demand for consumables. Major trends in the forecast period include advancements in portable technology, integration with digital health systems, integration with remote patient monitoring (RPM) and telemedicine platforms, integration within IoMT or connected health infrastructure, and edge computing and low-power biosensor chips.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp
  
 What Are the Major Factors Fueling Growth in the Point Of Care Lipid Test Market?
 The increasing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test market going forward. Cardiovascular diseases refer to disorders of the heart and blood vessels, including coronary artery disease, stroke, and hypertension, often caused by atherosclerosis linked to abnormal cholesterol and triglyceride levels. The growing prevalence of cardiovascular diseases are due to rising sedentary lifestyles and reduced physical activity, which contributes to obesity, poor circulation, and other risk factors for CVDs. Point-of-care lipid tests support the management of the increasing prevalence of cardiovascular diseases by providing quick, on-site measurement of cholesterol and other lipid levels, enabling early risk identification and prompt treatment decisions to prevent disease progression. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, in the cardiovascular sector, the number of deaths due to cardiovascular disease is reaching 931,578, which represents a rise of 3,000 fatalities compared to the previous year’s figure of 928,741. Therefore, the increasing prevalence of cardiovascular diseases is expected to propel the growth of the point of care lipid test market.
 
 What Are the Emerging Segments in the Point Of Care Lipid Test Market?
 The point of care lipid test market covered in this report is segmented as
 
 1) By Product Types: Instruments, Consumables, Other Product Types
 2) By Application: Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Hyperlipoproteinemia, Familial Hypercholesterolemia, Other Applications
 3) By End-User: Hospitals, Clinics, Diagnostic Laboratories, Home Care Settings, Other End Users
 
 Subsegments:
 1) By Instruments: Benchtop Analyzers, Portable Or Handheld Analyzers, Multi-parameter Analyzers, Single-parameter Analyzers
 2) By Consumables: Test Strips, Reagents And Kits, Quality Control Materials, Calibrators
 3) By Other Product Types: Software Solutions, Accessories, Data Management And Connectivity Tools
 
 
 What Are the Future Trends Forecasted for the Point Of Care Lipid Test Market?
 Major companies operating in the point-of-care lipid test market are focusing on innovative solutions, such as advanced point-of-care (POC) diagnostic platforms, to deliver rapid, accurate, and lab-quality lipid panel results at the patient’s bedside, improving clinical decision-making and patient management. An advanced point-of-care (POC) diagnostic platform refers to a portable, integrated device that performs rapid, accurate, and lab-quality tests near the patient, enabling real-time clinical decision-making and immediate health management. For instance, in July 2023, Vital Biosciences Inc., a Canada-based health technology company, launched a point-of-care lab testing platform called VitalOne, designed to deliver over 50 lab-grade blood test results within just 20 minutes using a compact, automated device at sites such as clinics and pharmacies. This combines hematology, clinical chemistry, and immunoassays in a single instrument, that enables healthcare providers to perform testing, diagnosis, and treatment in a single visit, radically improving access, speed, and personalization of patient care, all with accuracy comparable to traditional central labs.
 
 Which Are the Key Companies Shaping the Point Of Care Lipid Test Market Landscape?
 Major companies operating in the point of care lipid test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quidel Corporation, Bio-Rad Laboratories Inc., Horiba ABX SAS, Randox Laboratories Ltd., Sekisui Diagnostics LLC, Fisher Scientific International Inc., Everlywell Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, VivaChek Biotech (Hangzhou) Co. Ltd., EuroMedix International NV, A. Menarini Industrie Farmaceutiche Riunite S.r.l., AccuBioTech Co. Ltd., Callegari S.r.l., MiCo BioMed Co. Ltd., BHR Diagnostics Private Limited.
 
 Get the full point of care lipid test market report here:
 https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report
 
 What Are the Key Regional Trends in the Point Of Care Lipid Test Market?
 North America was the largest region in the point of care lipid test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care lipid test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company